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Abstract
Dosage compensation is a specialized form of gene regulation that balances sex-chromosome linked gene expression
between the sexes. In C. elegans, dosage compensation is achieved by the activity of the dosage compensation complex
(DCC). The DCC binds along both X chromosomes in hermaphrodites to down-regulate gene expression by half, limiting X-
linked gene products to levels produced in XO males. Sequence motifs enriched on the X chromosome play an important
role in targeting the DCC to the X. However, these motifs are not strictly X-specific and therefore other factors, such as the
chromatin environment of the X chromosome, are likely to aid in DCC targeting. Previously, we found that loss of HTZ-1
results in partial disruption of dosage compensation localization to the X chromosomes. We wanted to know whether other
chromatin components coordinated with HTZ-1 to regulate DCC localization. One candidate is DPY-30, a protein known to
play a role in DCC localization. DPY-30 homologs in yeast, flies, and mammals are highly conserved members of histone H3
lysine 4 (H3K4) methyltransferase Set1/MLL complexes. Therefore, we investigated the hypothesis that the dosage
compensation function of DPY-30 involves H3K4 methylation. We found that in dpy-30 animals the DCC fails to stably bind
chromatin. Interestingly, of all the C. elegans homologs of Set1/MLL complex subunits, only DPY-30 is required for stable
DCC binding to chromatin. Additionally, loss of H3K4 methylation does not enhance DCC mislocalization in htz-1 animals.
We conclude that DPY-30 and HTZ-1 have unique functions in DCC localization, both of which are largely independent of
H3K4 methylation.
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Introduction
The intricate regulation of gene expression that occurs in all
organisms is the result of the coordinated activity of multiple
machineries (RNA Polymerases, transcription factors, histone
modifiers, chromatin modifiers, etc.). In order for this to be
achieved, these machineries need to be targeted to very specific
sites of action within the vast expanse of the genome. How these
various proteins and complexes find their proper targets is an
important question to answer to further our understanding of how
gene regulation is ultimately achieved.
Here we discuss the targeting of a specialized gene regulatory
complex in C. elegans called the dosage compensation complex
(DCC). In organisms such as C. elegans, the difference in sex
chromosome number between the sexes, if left uncorrected, would
result in an imbalance of X-linked gene expression in the affected
sex. To correct this imbalance, the DCC is recruited to the two X
chromosomes in C. elegans hermaphrodites and dosage compen-
sated genes are down-regulated an average of two-fold to match
expression levels observed in the XO male (reviewed in [1,2,3]).
The DCC is comprised of a regulatory subcomplex composed of
SDC-1, SDC-2, SDC-3, DPY-30, and DPY-21, and an enzymatic
condensin complex comprised of DPY-27, MIX-1, CAPG-1,
DPY-28, and DPY-26 (condensin I
DC), similar to mitotic and
meiotic condensin complexes [1,4]. SDC-2 and SDC-3 can bind
to chromatin independent of the condensin complex but the
reverse is not true [5,6,7].
Although the gene regulation function of dosage compensation
in flies is opposite of worms, there are similarities in the X-
chromosome targeting mechanisms employed in the two species.
In D. melanogaster, dosage compensation is achieved by up-
regulation of the single male X chromosome by the MSL (male-
specific lethal) complex [8,9]. The initial targeting of the MSL
complex to the X chromosome occurs at chromatin entry sites or
high affinity sites containing GA-dinucleotide repeats [10,11]. The
entry sites are also specifically depleted of nucleosomes [10]. The
MSL complex then spreads locally onto the 39 ends of nearby
active genes [12,13,14]. The complex can identify active genes by
the specific recognition of H3K36 methylation at the 39 end of
genes by the subunit MSL3 [15]. Therefore, sequence informa-
tion, transcriptional status, and chromatin organization play key
roles in recruitment and spreading of the MSL complex in fly
dosage compensation [10,11,12,13,14,15,16].
DCC binding in C. elegans also involves a similar combination
of factors. Analysis of DCC binding by chromatin immunopre-
cipitation, as well as analysis of DCC binding to transgene
arrays, revealed the presence of multiple classes of DCC binding
sites [17,18,19,20,21]. Regions that can attract DCC binding
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and all other sites of DCC binding are called dox sites (for
dependent on X) [7,18,20]. We found at least one other class of
DCC binding sites that function as rex sites on multicopy
transgenic arrays, but fail to attract robust complex binding in
single copy chromosomal duplications [21]. We refer to such sites
as way-stations and predict that these sites assist in DCC spreading
downstream of recruitment. Motif searches of both recruiting
elements and regions with exceptionally high DCC occupancy led
to the identification of a 12 bp consensus sequence named MEX,
for Motif Enriched on X [17,18,20]. Regions of the X containing
MEX are able to recruit the DCC in vivo, indicating that the
sequence has recruitment function. However, neither the presence
of MEX nor high levels of DCC binding strictly correlate with the
ability to recruit the DCC [17,20,21], indicating that MEX is not
the sole driver of DCC recruitment.
Evidence suggests that transcriptional activity may also contri-
bute to DCC targeting. The DCC binds to promoter regions of
about half of all transcribed genes on X [17,18,22]. In an X:A
chromosomal fusion strain, binding to promoters of active genes
on the attached autosome is augmented. Furthermore, changes in
gene expression during development correlate with changes in
DCC binding [7,22]. These results indicate that transcriptional
activity may help attract the DCC independent of chromosome-
specific sequences [22]. Curiously, DCC-mediated gene expres-
sion changes do not correlate with the presence of DCC at the
promoter [18].
Chromatin organization also likely plays an important and as yet
incompletely understood role in C. elegans dosage compensation.
Indeed, previously we have shown that the H2A.Z variant in C. elegans
(HTZ-1) plays a role in regulating DCC targeting to the X
chromosomes [23]. H2A.Z is a histone variant conserved in all
eukaryotes and is essential in all organisms tested except yeast
[24,25,26].It ishighlyassociated with promoter regions, howeverthis is
not necessarily associated with active expression [27,28,29,30,31,32].
Although not fully understood, H2A.Z likely functions to positively
regulate gene expression [33,34,35,36,37,38,39]. H2A.Z displays
antagonistic activity with repressive chromatin complexes and
signatures [23,40,41,42,43,44]. In yeast, Htz1 is required to restrict
the spread of silencing complexes from the silent mating type loci and
telomeres[43,44,45].InArabidopsisandhuman cells,H2A.Zspecifically
antagonizes DNA methylation, a signature of long-term gene silencing
[40,42].
In C. elegans, HTZ-1 is found at significantly lower levels on the
X chromosomes than autosomes [23,29]. Depletion of HTZ-1 in
hermaphrodites leads to ectopic DCC localization and disrupts
dosage compensation [23]. Therefore, we hypothesized that HTZ-
1 functions to prevent autosomal binding of the DCC in
hermaphrodites, similar to the functions described in yeast,
Arabidopsis, and humans, in antagonizing the spread of gene
repression activities.
In search of other chromatin factors regulating DCC binding,
we decided to investigate the role of H3K4 methylation. In
budding yeast, Htz-1 cooperates with H3K4 methylation to
restrict genome-wide spreading of the SIR (Silent Information
Regulator) complex [44]. Additionally, loss of H3K4 methylation
by disruption of Set1 complex function results in increased
heterochromatin signatures (H3K27 and H3K9 methylation) at
chicken b-globin insulator elements [46]. H3K4 methylation is the
result of the function of Set1/MLL histone methyltransferase
complexes made up of a SET-domain containing methyltransfer-
ase (of the Set1 or MLL family) and at least four other subunits,
WDR5, RbBP5, Ash2L, and DPY-30 [47,48,49,50,51,52,
53,54,55,56]. Intriguingly, orthologs of the known dosage
compensation protein, DPY-30, are found in all Set1/MLL
complexes and contribute to methylation activity of the complexes
in other organisms [50,51,56,57,58,59]. DPY-30 binds ASH2L,
and also forms homodimers, allowing for dimerization of the
entire complex [58,59]. Without DPY-30, global levels of
H3K4me3 are significantly reduced in budding yeast, C. elegans,
and mammals [7,57,58,59,60,61]. Slight reductions of dimethyla-
tion have also been reported in budding yeast and C.elegans
[58,60].
In C. elegans, in addition to a global reduction in H3K4
methylation, dpy-30 mutant hermaphrodites exhibit DCC mis-
localization and impaired dosage compensation [7,62,63]. Recent
data suggest that DPY-30 function is important for DCC
recruitment in a similar fashion as the recruitment proteins
SDC-2 and SDC-3 [7]. Interestingly, the C. elegans Ash2L
homolog, ASH-2, can also be found at many recognition sites
and overlaps DCC binding at some genes [7]. Overall, current
evidence suggests that DPY-30 is a member of both DCC and
Set1/MLL complexes. However, it has not been tested whether
DPY-30 function in histone methyltransferase complexes, or
H3K4 methylation itself, contributes to dosage compensation. It
has recently been proposed that DPY-30 and H3K4 methylation
may assist in DCC spreading to sites of active transcription [2].
We decided to test whether HTZ-1 and H3K4 methylation
cooperate in regulating DCC binding, so that in concert with
sequence- and transcription-driven targeting, the DCC is targeted
correctly to the X chromosomes. We observed DCC localization
in Set1/MLL depleted animals and in htz-1 mutants depleted of
Set1/MLL subunits. Depletion of these components led to
decreased H3K4me3, as expected. However, we did not observe
a correlation between H3K4me3 reduction and effects on DCC
localization. Furthermore, DCC mislocalization in htz-1 animals
was not enhanced by reduced H3K4 methylation. We conclude
that H3K4 methylation does not signifcantly contribute to HTZ-1-
regulated DCC localization and that the function of DPY-30 in
DCC localization is largely independent of its role in Set1/MLL
histone methytransferase complexes.
Results
H3K4 is differentially methylated on the dosage
compensated X chromosomes
In order to investigate whether H3K4 methylation regulates
DCC localization we first observed the methylation status of
H3K4 on the dosage compensated X chromosomes at the
resolution of a single cell using immunofluorescence (IF) analysis
in adult hermaphrodite intestinal nuclei. We utilized antibodies
specific for the mono-, di-, and trimethylated forms of H3K4 along
with antibodies specific for subunits of the dosage compensation
complex (DCC) to label the X chromosomes. To compare
intensity of the methylated H3K4 species on the X chromosomes
to the rest of the nucleus, we measured the ratio of the average
H3K4me signal intensity in the DCC positive region compared to
the average intensity of the entire nucleus (see Materials and
Methods). We compared these results to measurements of HTZ-1
intensity on X which has been previously shown to be depleted on
the X chromosomes in hermaphrodite animals [23,29].
Interestingly, we found the average H3K4me3 intensity signal
to be reduced on the X by nearly 20% compared to the average
signal in the nucleus. This is almost identical to the reduction
observed for HTZ-1 signal intensity on X. H3K4me2 signal
intensity is the same, while the H3K4me1 signal is slightly
higher on the X chromosome compared to the rest of the nucleus
(Fig. 1). These results are consistent with the recent genome-wide
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difference in H3K4 methylation on X was observed with
H3K4me3 [64].
H3K4 differential methylation is not regulated by dosage
compensation
We next wanted to investigate whether the differences in
methylation levels on the X chromosomes are regulated by dosage
compensation. To do this we performed the same analysis as
described above in the dosage compensation mutants sdc-1(y415)
and dpy-21(e428). We chose these specific mutants because
although dosage compensation function is disrupted by these
mutations, the DCC still localizes to the X chromosome [65]. This
allows us to again utilize DCC specific antibodies to label the X.
The alternative method of labeling the X chromosome by X Paint
fluorescent in situ hybridization (FISH) was not possible as the
H3K4 methylation antibodies fail when combined with FISH.
For the most part, the differential methylation and differential
HTZ-1 levels on the X were unchanged in dosage compensation
mutants (Fig. 1). The only exception was in sdc-1 where the slight
enrichment of H3K4 monomethylation was lost. These results
indicate that differential H3K4me3 and HTZ-1 levels on the X
chromosome are not regulated by dosage compensation. The loss
Figure 1. H3K4 is differentially methylated on dosage compensated X chromosomes. A. IF of the DCC (red) and H3K4me1, H3K4me2,
H3K4me3 or HTZ-1 in wildtype, or dosage compensation mutants sdc-1(e415) and dpy-21(e428) shows slightly higher levels of H3K4me1 and lower
levels of both H3K4me3 and HTZ-1 on dosage compensated X chromosomes in adult hermaphrodite intestinal nuclei. DCC is marked by a DPY-27-
specific antibody (with H3K4me2, H3K4me3 and HTZ-1 co-stain) or a CAPG-1-specific antibody (with H3K4me1 co-stain). DAPI (grayscale) stains DNA.
Scale bar equals 5 mm. B. Quantification of H3K4 methylation and HTZ-1 occupancy on the dosage compensated X chromosomes by IF in wildtype
and dosage compensation mutants. The average intensity of H3K4 methylation or HTZ-1 signal was recorded for the nucleus and for the DCC-marked
X chromosome regions. The ratio of the average intensity on X versus the average intensity for the entire nucleus was calculated and the average
values are shown. Error bars indicate the standard deviation. Star indicates significant difference from wildtype by t-test analysis (p=6610
23).
doi:10.1371/journal.pone.0025973.g001
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sation may be responsible for monomethylation enrichment on the
X chromosomes. However, the fact that enrichment is still
observed in dpy-21 mutants indicates that there is no strict
correlation between loss of enrichment and loss of dosage
compensation function.
DPY-30 is required for DCC localization and binding to
chromatin
Next, we wanted to understand the effect of the Set1/MLL
component DPY-30 on DCC localization at the resolution of a
single cell. Previously, DPY-30, a subunit of Set1/MLL, was
described to cause DCC mislocalization [63] and very recently was
shown to be required for DCC recruitment to the X by ChIP-chip
analysis in mixed stage embryo preparations [7]. Whether this
phenotype is due to changes in H3K4 methylation has not been
addressed. We utilized DPY-27 IF combined with X-Paint FISH
to observe the extent of DCC mislocalization in homozygous dpy-
30(y228) mutant animals decended from heterozygous mothers
(m+z). DPY-30 is maternally provided to these progeny, but the
zygote does not produce fully functional protein.
In dpy-30 nuclei, DPY-27 has a completely diffuse, nuclear
appearance with inconsistent overlap with the X chromosomes
(Fig. 2A). The signal is so diffuse that we hypothesized that the
DCC was not bound to chromatin, but rather largely nucleoplas-
mic. To test this we performed a detergent extraction prior to
fixing the tissue to remove nucleoplasmic content. What we
observed was striking- most of the DPY-27 signal was lost upon
extraction. This strongly suggests that DPY-30 is required for the
complex to stably bind chromatin. These results are in contrast to
what we observe in htz-1(tm2469). As reported previously, htz-1
animals exhibit ectopic DCC localization to autosomes and this
ectopic signal is not sensitive to detergent extraction (Fig. 2A and
[23]. Therefore, while both DPY-30 and HTZ-1 affect DCC
localization, they do so in a markedly different manner.
Previously, it was shown that DCC assembly on the X
chromosome required all subunits such that the absence of one
component affected the stability or localization of the rest of the
complex [4,66,67,68,69]. Because of this, we hypothesized that the
DCC as a whole was mislocalized in dpy-30 animals, rather than
DPY-27 on its own. To address this we observed three other
members of the complex, MIX-1, CAPG-1, and DPY-28 by IF in
dpy-30 nuclei. All of these components had a diffuse, nuclear
pattern in dpy-30 exactly as we observe for DPY-27 (Fig. 2B). This
result strongly suggests that the DCC as a whole cannot load onto
chromatin in dpy-30 animals.
Set1/MLL depletion affects H3K4 methylation, but not
DCC localization
We next wanted to test whether the loss of Set1/MLL subunits
other than DPY-30 has a similar effect on DCC localization. We
hypothesized that the role of DPY-30 in dosage compensation was
linked with its function in the histone methyltransferase complexes
and predicted that loss of other Set1/MLL subunits would also
disrupt DCC binding to chromatin. To test this, we depleted
individual members of the Set1 and MLL complexes by RNAi and
observed DCC localization in the adult animals. Although we
tested all homologs by RNAi, we focused on the two SET-domain
containing genes set-2 (homologous to Set1 in yeast, Set1A in
humans) and set-16 (homologous to MLL2/3 in mammals) as well
as ash-2 (homologous to Bre2 in yeast and Ash2L in humans) and
hcf-1 (homologous to human Hcf1).
We focused on set-2 and set-16 as these are the only genes in C.
elegans homologous to H3K4 methyltransferases in other organisms
and have been shown previously to function in H3K4 methylation
[60,61,70,71]. We focused on ash-2 because the homologs in other
organisms are known binding partners of DPY-30 in Set1/MLL
Figure 2. DCC binding to or stability on chromatin is compromised in dpy-30 animals. A. DCC localization by DPY-27 IF (green) combined
with X-paint FISH (red) with and without detergent extraction of nucleoplasmic contents in wildtype, dpy-30(y228), and htz-1(tm2469) hermaphrodite
intestinal nuclei shows that the diffuse DCC localization observed in dpy-30 animals can be extracted with detergent treatment while the mislocalized
DCC in htz-1 cannot. B. Condensin I
DC components mislocalize in dpy-30(y228) hermaphrodite animals. DPY-27, DPY-28, CAPG-1, and MIX-1 (green) all
show the same diffuse, nuclear pattern in hermaphrodite adult intestinal nuclei. DPY-27 localization in wildtype (WT) is shown as a control. The
nuclear envelope is marked with a nuclear pore complex antibody (red) as a staining control. In all panels DAPI is shown in grayscale and scale bar
equals 5 mm.
doi:10.1371/journal.pone.0025973.g002
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activity [57,58,59]. Finally, we chose hcf-1 because the mammalian
homologs, in addition to being a physical component of Set1/
MLL, serve as molecular tethers between MLL and other
chromatin modifying complexes [54,72,73]. To observe the effect
of individual subunit depletion on Set1/MLL complex activity we
analyzed H3K4me3 levels by IF and western blot as loss of
individual components in other systems affects this modified form
most dramatically [49,50,58,59,74]. We also analyzed H3K4me2
and H3K4me1 levels by IF and western blot upon depletion of
SET-2, SET-16, ASH-2, HCF-1, and DPY-30.
We found that depletion of each individual Set1/MLL subunit
homolog led to a reduction in H3K4me3 (Fig. 3 and Fig. S1). This
is consistent with the fact that full H3K4 methyltransferase activity
by the Set1/MLL complex requires all subunits in yeast and
mammals [49,57,58,59,74,75,76,77,78]. By contrast, mono and
di-methylation signals were less affected (Fig. S2). Only depletion
of the catalytic subunits SET-2 and SET-16 reduced H3K4me2
and H3K4me1 signals. Depletion of ASH-2 leads to a reduction in
di- and trimethylation, consistent with published in vivo analysis in
budding yeast and mammals [58,59,74,76,78]. In mammals,
heterodimers of Ash2L and RbBP5 exhibit SET-independent
monomethylation activity in vitro [79], however, we do not observe
any change in H3K4 monomethylation levels in ASH-2 depleted
animals. DPY-30 and HCF-1 depletion animals showed reduced
H3K4me3 by IF, but di- and monomethylation signals were
unchanged (Fig. S2). As a control, we also analyzed H3K27me3
signal by IF in Set1/MLL depletion and mutant animals and
found no striking change in H3K27me3 signal, as expected (Fig.
S3). Western blot analysis confirmed what was observed by IF:
SET-2 and SET-16 depletion leads to reductions in all forms of
H3K4 methylation, ASH-2 depletion affects di- and trimethyla-
tion, and DPY-30 depletion specifically affects H3K4 trimethyla-
tion in young adult hermaphrodites (Fig. S4). Analysis of set-
2(ok952) and hcf-1(ok559), both hypomorph deletion mutants
[80,81], as well as set-2(bn129) and wdr-5.1(ok1417), both null
deletion mutants [60,81], led to similar conclusions. The decrease
in methylation levels in the set-2(ok952) and hcf-1(ok559) mutants
was less severe than after RNAi depletion (Fig.S5). Analysis of
H3K4 methylation in both the set-2(bn129) as well as a wdr-
5.1(ok1417) null strains revealed stronger effects on H3K4me3 and
H3K4me2 in particular (Fig. S5).
Surprisingly, the only Set1/MLL component that also affects
DCC localization is dpy-30. Depletion of DPY-30 by RNAi leads
to the same diffuse, nuclear DCC localization pattern as we
observe in the dpy-30 mutant. In all other Set1/MLL depletion
animals, the level of H3K4me3 staining was similar to DPY-30
depletion animals, but the DCC staining pattern appeared exactly
as in controls (Fig. 3, Fig. S1). The results of depletion of the
individual Set1/MLL subunits along with the names of their
respective S. cerevisiae and human homologs are summarized in
Table 1.
Figure 3. Depletion of Set1/MLL subunits by RNAi leads to
reduction in H3K4me3 levels. H3K4me3 (green) and DPY-27 (red) IF
in control RNAi and Set1/MLL depletion animals shows a reduced
H3K4me3 signal upon Set1/MLL RNAi in adult intestinal nuclei. Note
that only DPY-30 depletion leads to a diffuse DCC localization
phenotype. In all panels DAPI is shown in grayscale and scale bar
equals 5 mm.
doi:10.1371/journal.pone.0025973.g003
Table 1. Summary of Set1/MLL depletion.
S. cerevisiae Human C. elegans H3K4me3 DCC
SET1 hSET1 set-2 reduced WT
MLL2/3 set-16 reduced WT
SWD1/Cps50 RbBP5 F21H12.1 reduced WT
SWD3/Cps30 WDR5 wdr-5.1 reduced WT
swd-3.2 reduced WT
swd-3.3 reduced WT
SWD2/Cps35 WDR82 swd-2.1 reduced WT
swd-2.2 reduced WT
WDR83 F33G12.2 reduced WT
SPP1/Cps40 CFP1 F52B11.1 reduced WT
BRE2/Cps60 Ash2L ash-2 reduced WT
SDC1/Cps25 hDPY30 dpy-30 reduced Diffuse
HCF1/2 hcf-1 reduced WT
The Set1/MLL homologs tested in this study are shown. Names of budding
yeast and mammalian homologs are included for reference. Depletion of each
subunit led to reduced H3K4me3 by IF or a combination of IF and western. Only
dpy-30 depletion resulted in diffuse DCC localization. In all other Set1/MLL
depletion animals, DCC localization appeared wild-type (WT).
doi:10.1371/journal.pone.0025973.t001
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depletion animals except dpy-30, we wanted to be certain that the
DCC was truly localizing to the X chromosomes. Again, we
combined DCC IF with X-Paint FISH to observe DCC
localization on the X chromosomes in Set1/MLL depletion
animals. We found that the DCC signal colocalized with the X-
Paint signal in the Set1/MLL depletion animals similar to the
control (Fig. 4A). Additionally, the two null strains, set-1(bn129)
and wdr-5.1(ok1417), showed no significant change in DCC
localization compared to wildtype hermaphrodites, further
demonstrating that loss of these components does not significantly
affect DCC localization (Fig. 4B).
We next hypothesized that residual Set1/MLL activity
remaining upon depletion of only one component prevented us
from observing a change in DCC localization. To address this, we
performed RNAi depletion of SET-2, SET-16, ASH-2, and HCF-
1 in the set-2(ok952) deletion mutant background. We observed
further reductions of H3K4me3 (Fig. 5), H3K4me2, and
H3K4me1 signals (Fig. S6). We still did not observe any obvious
change in DCC localization in these animals. This result suggests
that Set1/MLL complexes and H3K4 methylation are not
involved in dosage compensation at the level of DCC localization
and stability on chromatin. These data also indicate that DPY-30’s
role in DCC localization is likely to be independent of its function
in H3K4 methylation.
Set1/MLL complexes do not cooperate with htz-1 to
restrict DCC localization
Although neither Set1 nor MLL complexes appear to play a
role in DCC localization or binding to chromatin on their own, it
is possible that these complexes may function with other
chromatin components to affect DCC localization. Previous work
in budding yeast has demonstrated that Set1C cooperates with the
histone variant H2A.Z/Htz1 to limit genome-wide mislocalization
of the SIR complexes [44]. Our lab has shown that loss of HTZ-1
in C. elegans results in partial mislocalization of the DCC to
autosomes [23]. We therefore wanted to test whether H3K4
methylation defects enhance DCC mislocalization in htz-1
Figure 4. DCC localization to the X chromosomes is disrupted
in dpy-30 depleted and mutant animals but not in other Set1/
MLL depletion and mutant animals. DPY-27 (green) and X-Paint
FISH (red) in control and Set1/MLL depletion (A) and mutant (B)
animals. In all panels DAPI is shown in grayscale and scale bar equals
5 mm.
doi:10.1371/journal.pone.0025973.g004
Figure 5. Severe loss of H3K4 methylation by Set1/MLL
depletion in set-2(ok952) hermaphrodites. Hermaphrodite intesti-
nal nuclei co-stained for H3K4me3 (green) and DPY-27 (red) in Set1/MLL
complex depletion in set-2 mutant animals demonstrates that increased
loss of H3K4 methylation does not correlate with DCC mislocalization. In
all panels DAPI is shown in grayscale and scale bar equals 5 mm.
doi:10.1371/journal.pone.0025973.g005
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1(tm2469)m+z- background. We then used DCC IF combined with
X-Paint FISH to visualize DCC localization to the X chromo-
somes at the single cell resolution. To measure the degree of DCC
mislocalization we measured colocalization of the DCC and X-
Paint signals using Slidebook software. The result of this analysis is
a Pearson’s correlation value (R) where 1 represents complete
colocalization of the signals and 0 represents no measureable
colocalization [23].
Colocalization analysis in the htz-1 mutant background revealed
that the degree of DCC mislocalization is unchanged upon Set1/
MLL depletion (Fig. 6). A majority of the colocalization values
collected in wildtype treated with empty vector RNAi are above
0.5 (16/18) and the average R is 0.61. The average R value in
htz-1 homozygous animas treated with vector control RNAi is
significantly lower than wildtype (0.47). The average R (0.43–0.48)
and profiles for Set1/MLL depletion are very similar to empty
vector controlRNAi in the htz-1 homozygous background. We used
one-way ANOVA analysis to determine whether there was any
statistical difference among the colocalization data collected. When
comparing the control and Set1/MLL RNAi samples in the htz-1
background, no statistical difference was observed. However,
additionof the controlRNAi in wildtype data indicated a significant
difference (F=4.29, FCrit=2.30, P=0.0014). By Tukey’s test, the
significant differences in colocalization are found between the
wildtype control and each of the htz-1 background samples and not
between the htz-1 control and the Set1/MLL RNAi samples in the
htz-1 background (Fig. S7). We conclude that depletion of H3K4
methylation does not enhance the DCC mislocalization defect
observed in htz-1 mutants.
Figure 6. Reduced H3K4 methylation by Set1/MLL depletion does not enhance DCC mislocalization in htz-1(tm2469). DPY-27 (green)
and X-Paint FISH (red) colocalization analysis upon Set1/MLL depletion in htz-1(tm2469)m+z- mutant animals indicates that reduced H3K4
methylation does not further disrupt DCC localization. In all panels DAPI is shown in grayscale and scale bar equals 5 mm. B. Quantification of
colocalization by Pearson’s correlation coefficient R indicating the degree of overlap between the DCC and X-Paint masks. R measurements were
binned every 0.1 from 0 to 1 (where 0 indicates no detectable overlap and 1 indicates perfect colocalization) and percent of total sample per bin is
shown. See Figure S7 for statistical analysis.
doi:10.1371/journal.pone.0025973.g006
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compensation
To confirm that changes in H3K4 methylation do not influence
dosage compensation function, we utilized a genetic assay to test
whether Set1/MLL complex subunits contribute genetically to
dosage compensation. In this sensitized genetic assay we deplete
components of the Set1/MLL complexes by RNAi in the him-8
xol-1 sex-1 mutant background [4,23]. The him-8 mutation results
in an average 38% male progeny. However, the xol-1 mutation
turns on dosage compensation and all male progeny die as a result
[82]. The sex-1 mutation weakens dosage compensation function,
thereby sensitizing the assay [83]. Therefore, RNAi depletion of a
gene required for dosage compensation function will rescue some
of the males in this background.
The DCC component capg-1 results in significant male rescue in
this assay. However, the only Set1/MLL component with
significant male rescue was dpy-30 (p=6.83610
25 by t-test
analysis) (Fig. 7). This suggests that dpy-30 is unique among
Set1/MLL components in its contribution to dosage compensa-
tion function. Combined with the data outlined above we
conclude that the function of DPY-30 in dosage compensation is
largely separate from its role in H3K4 methylation.
Discussion
It has long been hypothesized that chromatin organization plays a
substantial role in driving protein complexes to their proper targets
within the genome. The predicted mechanism is that chromatin
organization blocks access to all but a subset of potential binding sites
at any given time. In support of this, functional transcription factor
binding sites are commonly depleted of nucleosomes in human T-
cells [27]. Also,in C. elegans, ectopic expression of the pharynx-specific
transcription factor, PHA-4 in intestinal cells does not result in
binding of PHA-4 to pharynx-specific genes, suggesting that these
sites are unavailable for binding in the intestinal nuclei [84]. A survey
of 21 transcription factor binding profiles in Drosophila has recently
revealed that chromatin accessibility is a better predictor of target site
occupancy than in vitro affinity [85]. Targeting of the X-chromosome
specific DCC in C. elegans also involves both sequence and chromatin
organization [17,18,20,23].
Recently, it has become increasingly clear that in C. elegans the X
and autosomal chromatin makeup is significantly different both at
the population level by high resolution ChIP-chip and single-cell
resolution microscopy studies [23,64,86,87]. HTZ-1 was the first
reported chromatin component found to be differentially incor-
porated on the dosage compensated X chromosomes [23,29].
More recently, H4K20me1 and H3K27me1 were found at higher
levels on X and it was suggested that this may be functionally
important for gene regulation on the X chromosomes [64]. We
have found that the dosage compensated X chromosomes have
reduced levels of H3K4me3, similar to what has been reported for
HTZ-1, and slightly higher levels of H3K4me1. Depletion of
H3K4me3 and HTZ-1 are both independent of dosage compen-
sation, but enrichment of monomethylated H3K4 may be subject
to regulation by dosage compensation. The fact that loss of dosage
compensation function in sdc-1 animals abolishes enrichment of
H3K4me1 suggests that the transcriptional regulation function of
dosage compensation may involve H3K4me1. However, the fact
that we do not observe any changes in DCC localization in the
Set1/MLL depletion animals with lowest H3K4me1 signal (set-2
or set-16(RNAi) in set-2 mutant animals, see Fig. 5), suggests that if
there is a role for monomethylation of H3K4, it is likely
downstream of DCC localization. We did not detect any genetic
function of either set-2 or set-16 in dosage compensation,
suggesting that the overall contribution of H3K4me1 to
chromosome-wide gene regulation by the DCC may be minor.
Alternatively, the function of an as-yet unidentified methyltranfer-
ase may be responsible for the enrichment of H3K4me1 on the X
chromosomes and this methyltransferase may function in dosage
compensation. This hypothesis could be tested in the future by
looking for expression changes of dosage compensated genes in
animals with reduced H3K4me1 and by testing other methyl-
transferase genes for function in dosage compensation.
An attractive hypothesis was that the depletions of HTZ-1 and
H3K4me3 on the X chromosomes function as an X-chromatin
signature utilized by dosage compensation to selectively bind the X
in hermaphrodites. Further support for this hypothesis was the fact
that the Set1/MLL component DPY-30 is required for both
normal levels of H3K4me3, and is required for dosage
compensation (see figures 3 and S2) [60]. However, the fact that
we did not observe disruption of DCC localization or an
enhancement of DCC mislocalization in htz-1 upon depletion of
H3K4me3 by Set1/MLL depletion or mutation suggests that this
is unlikely (Figures 4, 5, 6). Additionally, the striking difference in
DCC mislocalization phenotypes in dpy-30 and htz-1 mutant
animals is consistent with these factors regulating DCC localiza-
tion in distinct ways (Fig. 2).
Upon depletion or mutation of all of the Set1/MLL homologs
in C. elegans, we observed effects on global methylation in a manner
consistent with what is known about the complex function in
previous work (Fig. 3, S1, S2, S5 and S6). DPY-30 actually has a
less severe effect on overall methylation than does ASH-2 or the
catalytic subunits SET-2 and SET-16 (Fig S4). In spite of the more
severe effect on methylation levels upon depletion of ASH-2, SET-
2, and SET-16, we observed no effect on DCC localization.
Additionally, the reduced H3K4me3 we observe in Set1/MLL
complex depletion or mutant animals does not correlate with an
effect on DCC binding to chromatin. Therefore, the role of
Figure 7. H3K4 methylation compexes do not function in
dosage compensation. Rescue of sensitized male animals in which
the xol-1 mutation has ectopically turned on dosage compensation is
used as a measure of genetic function of dosage compensation.
Depletion of DCC subunit CAPG-1 by RNAi is able to disrupt ectopic
dosage compensation, rescuing about 40% of expected male progeny.
The only Set1/MLL complex subunit depletion with significant male
rescue is dpy-30. Star indicates p,0.05 by T-test (p=6.83610
25 for dpy-
30 and p=1.03610
29 for capg-1).
doi:10.1371/journal.pone.0025973.g007
DPY-30, HTZ-1 Function in DC Unaffected by H3K4me
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e25973DPY-30 in DCC targeting is likely to be independent of its activity
in known H3K4 methyltransferase complexes. Finally, genetic
analysis revealed no evidence for Set1/MLL function in dosage
compensation (Fig. 7).
How does DPY-30 contribute to dosage compensation if not
through the Set1/MLL complexes? Current evidence indicates a
physical interaction between DPY-30 and the DCC recruitment
protein SDC-2. DPY-30 immunoprecipitation pulls down SDC-2
(although a reciprocal interaction was not observed), and DPY-30
is found at DCC binding sites in an SDC-2 dependent manner [7].
The binding domains that have been mapped by structure-
function analyses between Ash2L/DPY-30 in mammals and
Bre2/Sdc1 in budding yeast [58] are not found in SDC-2 nor in
any of the other known dosage compensation proteins by blast
analysis (although the C. elegans ASH-2 is identified in these
searches). The proposed interaction between SDC-2 and DPY-30,
if direct, is likely through a domain entirely different from the
ASH-2 interacting domain, or the interaction may be indirect,
requiring an unidentified intermediate. The DPY-30 homolog in
yeast, Sdc1, functions in the dimerization of the whole complex
through interactions with Bre2 (ASH-2) and in homodimer
formation [58,59,88]. DPY-30 may play a similar role within the
DCC, aiding the assembly of the DCC onto SDC-2.
The unique DCC mislocalization phenotype of dpy-30 animals
suggests that DPY-30 plays a distinct role in dosage compensation.
In sdc-2 mutant adult nuclei, IF experiments revealed loss of the
Condensin I
DC signal ([4] and unpublished results). Although
Pferdehirt et al 2011 report that DPY-27 levels are unchanged in
sdc-2 embryos, the loss of signal in adults suggests that over the
course of development, DCC proteins are lost. However, in dpy-30
adults, the DCC, although grossly mislocalized, is still easily
detectable. In dpy-30 embryos, binding of DCC proteins DPY-27
and SDC-3 is nearly absent at sites involved in recruitment,
identical to the effect of sdc-2 mutation. It would be interesting to
test how dpy-30 affects SDC-2 levels and localization. It is possible
that SDC-2 is specifically required for the long-term stability of the
DCC as well as chromosome specific loading onto the X. In that
case, if SDC-2 is not able to bind chromatin, its presence in the
nucleus may still be able to perform its DCC stabilizing function.
Then we would predict that dpy-30’s function in dosage
compensation is to facilitate SDC-2-specific binding on chromatin
such that loss of dpy-30 results in failure of SDC-2 to ‘‘anchor’’ the
stable complex to chromatin. The overall effect on complex
localization would be specific loss of DCC at sites where SDC-2 is
absolutely required for DCC binding. Alternatively, sdc-2 may be
required for positively regulating expression of the other dosage
compensation genes in addition to directing DCC loading onto the
X. All DCC proteins except SDC-2 are maternally loaded into
oocytes, which could account for the similarity in DPY-27 levels in
sdc-2 and wild-type embryos. Eventually this maternally provided
DCC supply is lost in sdc-2 animals. Whether sdc-2 regulates DCC
expression at the level of protein stability or transcription could be
discerned by observation of mRNA and protein levels in
developing sdc-2 embryos. Understanding the nature of the
DPY-30-SDC-2 interaction in dosage compensation will be the
crucial first step in understanding how DPY-30 promotes DCC
binding and may also shed light on novel Set1/MLL-independent
functions of DPY-30 in other organisms.
Materials and Methods
Strains and alleles
All strains used were maintained as described [89]. Strains
include N2 Bristol strain (wildtype); TY4403 him-8(e1489) IV;
xol-1(y9) sex-1(y263) X; TY4161sdc-1(e415) and TY3936 dpy-
21(e428); TY1936 dpy-30(y228)/nT1[unc-?(n754dm)let-?];EKM11
htz-1(tm2469)IV/nT1(qIs51) IV,V; EKM32 hcf-1(ok559)IV;a n d
EKM31 set-2(ok952)III. Null mutants set-2(bn129)III and wdr-
5.1(ok1417)III (gifts of F.Palladino) were also used. hcf-1(ok559)
and set-2(ok952) were back-crossed four times prior to analysis.
Analysis of dpy-30(y228) and htz-1(tm2469) was performed in m+z-
animals.
RNA interference
E. coli HT115 bacteria expressing double stranded RNA for
capg-1, set-2,dpy-30, hcf-1, F52B11.1 (CFP1 homolog), F21H12.1
(RbBP5 homolog), wdr-5.1, swd-3.2, swd-3.3, swd-2.1, and swd-2.2
or vector control (polylinker), were used for feeding RNAi using
the Ahringer feeding RNAi clones [90]. To generate RNAi vectors
for set-16 and the 39 ash-2 the regions were PCR amplified,
digested with NotI and XhoI (set-16) or XhoI and SpeI (ash-2), and
cloned into the DT7 vector as described [90]. The following
primers were used for amplification:
set-16:
cgcggccgccgagcaacaacagggag and cctcgaggctgagaaggctgtttgc
ash-2:
gactcgaggctacacgttcacctgcaaa and tgactagtgccattcctttttctgcttg
RNAi experiments for IF/FISH and to score male rescue in
him-8(e1489) IV; xol-1(y9) sex-1(y263) X were conducted as
described [23]. Briefly, L1/L2 animals were grown on feeding
RNAi plates at 20uC until the L4 stage. Five to ten L4
hermaphrodites were then moved onto fresh feeding RNAi plates
for 24 hours at 20uC to throw progeny. Adult (P0) animals were
burned off the next day and their progeny were grown at 20uC.
For the male rescue assay the number of embryos laid was counted
at this time. Male counts were performed 3 days later. The F1
progeny were analyzed for IF/FISH 24 hours post-L4 (young
adults).
Immunostaining
Adult animals were dissected and stained as described [19].
Millipore Anti-Monomethyl Histone H3 (Lys4) rabbit polyclonal
antibody (cat # 07-436) was used at 1:100 dilution. Abcam H3
dimethyl K4 goat polyclonal antibody (ab11946) was used at
1:100. Millipore Anti-Trimethyl Histone H3 (Lys4) clone
CMA304 mouse monoclonal antibody (Cat. #05-1339) was used
at 1:100. Upstate anti-trimethyl-Histone H3(Lys27) (Cat. #17-
622) rabbit polyclonal was used at 1:200 Affinity purified
polyclonal rabbit anti-DPY-27 and polyclonal rat anti-CAPG-1
[4] were used at 1:100. Polyclonal rabbit anti-DPY-28 (gift of K.
Hagstrom) was used at 1:500 and polyclonal rabbit anti-MIX-1
(gift of R. Chan) was used at 1:100. Mouse monoclonal Anti-a-
tubulin by Sigma (T6199) was used at 1:500. Mouse monoclonal
antibody [Mab414] to Nuclear Pore Complex Proteins by Abcam
(ab24609) was used at 1:1000. Secondary antibodies used are:
Fluorescein (FITC) conjugated donkey a-rabbit (Jackson Immu-
noResearch) and Cy3 conjugated donkey a-rabbit IgG (Jackson
ImmunoResearch) both at a dilution of 1:100. Images were
captured with a Hamamatsu ORCA-ERGA CCD camera
mounted on an Olympus BX61 motorized X-drive microscope
using a 60X oil immersion objective. Captured images were
deconvolved using 3i Slidebook imaging software. Projected
images were taken at 0.2 mm intervals through samples. Adobe
Photoshop was used for assembling images.
Fluorescent in situ hybridization
FISH probe templates were generated by degenerate oligonucle-
otide primed PCR to amplify purified yeast artificial chromosome
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described [19]. Hybridization was performed on young adult
animals (24 hours post-L4) as described [23].
Quantification of fluorescence levels and colocalization
3-D z-stack images of nuclei were collected as described above.
3i Slidebook imaging software was used to set masks of histone
modification/variant localization (H3K4 me1, me2, me3, and
HTZ-1) and DCC localization on the 3-D image (although 3-D
projections are shown in Fig.1, projections were not used for
quantification). The histone modification/variant mask was used
to determine the average fluorescence intensity for the histone
modification/variant in the whole nucleus. The DCC mask was
used to determine the average fluorescence intensity for the
histone modification/variant signal specifically on the X chromo-
somes. The ratio of histone modification/variant signal on X
versus the nucleus as a whole was determined by dividing the
average signal intensity in the DCC mask divided by the average
signal intensity of the histone modification/variant mask.
3i Slidebook imaging software was used to measure colocaliza-
tion of DPY-27 (FITC) and X-Paint (Cy3) signals on images
obtained as described above. The FITC:Cy3 correlation coeffi-
cient was recorded and used as an indication of colocalization
between DPY-27 and X-Paint as described [23].
Detergent extraction
Detergent extraction of nucleoplasmic protein from dissected
nuclei was performed by dissecting animals in 1X sperm salts plus
1% Triton detergent [91]. Dissected animals were then processed
for Fluorescent in situ hybridization followed by immunofluores-
cence.
Western blot analysis
100 (2X lanes) and 50 (1X lanes) young adult Set1RNAi worms
(24 hours post-L4) were picked into 1XM9, washed, and incubated
for ten minutes at 95uCi n1 9ml SDS-PAGE loading dye (0.1 M
Tris-HCl pH 6.8, 75 M Urea, 2% SDS, Bromophenol Blue for
color) plus 1 ml b-mercaptoethanol. 10 ul of the worm extract in
loading buffer was loaded per lane into a 15% polyacrylamide gel.
SDS-PAGE was performed and protein was transferred onto
nitrocellulose. The following antibodies and dilutions were used:
Millipore Anti-Monomethyl Histone H3 (Lys4) rabbit polyclonal
antibody at 1:500, Abcam H3 dimethyl K4 goat polyclonal
antibody at 1:1000, Anti-Trimethyl Histone H3 (Lys4) clone
CMA304 mouse monoclonal antibody at 1:1000, and mouse
monoclonal Anti-a-tubulin at 1:1000. Secondary antibodies used
were as follows: anti-mouse-HRP, anti-goat-HRP, and anti-rabbit-
HRP (Jackson ImmunoResearch) all at 1:5000.
Supporting Information
Figure S1 Depletion of Set1/MLL components reduces
H3K4me3 but does not affect DCC binding. H3K4me3
(green) and DPY-27 (red) IF in control RNAi and Set1/MLL
depletion animals shows a reduced H3K4me3 signal upon Set1/
MLL RNAi in adult, hermaphrodite intestinal nuclei. The names
of the mammalian homologs are included for reference. In all
panels DAPI is shown in grayscale and scale bar equals 5 mm.
(TIF)
Figure S2 H3K4me1 and me2 in Set1/MLL depletion
nuclei. A. H3K4me1 (green) and CAPG-1 (red) co-staining in
control and Set1/MLL depletion nuclei (adult intestine). Reduc-
tion in H3K4me1 is only observed in SET-2 and SET-16
depletion animals. B. H3K4me2 (green) and DPY-27 (red) co-
staining slight reductions in signal are observed in all Set1/MLL
depletion nuclei except in dpy-30. In all panels DAPI is shown in
grayscale and scale bar equals 5 mm.
(TIF)
Figure S3 H3K27me3 signal unchanged in Set1/MLL
depletion and mutant adults. H3K27me3 (green) and DPY-
27 (red) co-staining in control and Set1/MLL depletion (A) and
mutant (B) nuclei reveal no change in H3K27Me3 staining. In all
panels DAPI is shown in grayscale and scale bar equals 5 mm.
(TIF)
Figure S4 H3K4 methylation levels upon Set1/MLL
depletion in wild-type, hermaphrodite adults. Western
blot analysis of H3K4 methylated species in young adult
hermaphrodites (100 and 50 per lane). H3K4me1 is reduced in
set-2 and set-16. H3K4me2 levels are reduced in all except dpy-30.
H3K4me3 levels are reduced in set-2, set-16, ash-2, and dpy-30. a-
Tubulin is used as a loading control.
(TIF)
Figure S5 H3K4 methylation in set-2, hcf-1, and wdr-5.1
deletion mutants. H3K4 methylation staining is in green, DPY-
27 (with H3K4me2 and me3 co-stain) and CAPG-1 (with
H3K4me1 co-stain) is shown in red. hcf-1(ok559) adult intestinal
nuclei show reduced H3K4me3 staining, while set-2(ok952), a
hypomorphic allele, set-2(bn129) and wdr-5.1(ok1417) both null
alleles [81] show reductions in all marks to varying degrees. No
DCC localization/binding phenotype is observed in these
backgrounds. In all panels DAPI is shown in grayscale and scale
bar equals 5 mm.
(TIF)
Figure S6 H3K4me1 and me2 after Set1/MLL depletion
in set-2(ok952) adults. A. H3K4me1 (green) and CAPG-1 (red)
IF and B. H3K4me2 (green) and DPY-27 IF in adult intestinal
nuclei. Although effects on methylation can be detected, there is
no effect on DCC localization in the set-2 mutant and Set1/MLL
depletion animals.
(TIF)
Figure S7 Statistical analysis of X-Paint/DCC colocali-
zation study in htz-1(tm2469) background. One-way
ANOVA of all colocalization data reveals statistically significant
differences between samples. When the wildtype control data is
omitted, the null is accepted. Tukey’s test reveals that the
significant differences between samples are specifically between
the wildtype control and each of the htz-1 (control and Set1/MLL
depletion) samples.
(TIF)
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